subscribeSubscribe
FDA Alerts Patients and Health Professionals to Nitrosamine Impurity Metformin

FDA Alerts Patients and Health Professionals to Nitrosamine Impurity Metformin
PRNEWSWIRE
28 May 2020
Share Share
Contaminated diabetes drugs raise red flag for FDA oversight

Contaminated diabetes drugs raise red flag for FDA oversight
Jacob Bell BIOPHARMADIVE
28 May 2020
Share Share
FDA Seeks Withdrawal of Heartburn Drugs Due to New Carcinogen Concerns

FDA Seeks Withdrawal of Heartburn Drugs Due to New Carcinogen Concerns
Z. Brennan RAPS
02 Apr 2020
Share Share
Glenmark Pharmaceuticals Inc., USA Voluntarily Recalls All Unexpired Lots of its Ranitidine

Glenmark Pharmaceuticals Inc., USA Voluntarily Recalls All Unexpired Lots of its Ranitidine
FDA
18 Dec 2019
Share Share
FDA warns of carcinogen found in diabetes drugs outside of US

FDA warns of carcinogen found in diabetes drugs outside of US
Amy Lieu FOX10
11 Dec 2019
Share Share
NDMA investigation leads to cases discovered in diabetes treatment

NDMA investigation leads to cases discovered in diabetes treatment
Ben Hargreaves IN-PHARMATECHNOLOGIST
10 Dec 2019
Share Share
Class 2 Medicines recall: Ranitidine 150mg/10ml Oral Solution (EL (19)A/29)

Class 2 Medicines recall: Ranitidine 150mg/10ml Oral Solution (EL (19)A/29)
GOVUK
25 Oct 2019
Share Share
Sanofi and Dr Reddy’s join the ranitidine recall

Sanofi and Dr Reddy’s join the ranitidine recall
Ben Hargreaves IN-PHARMATECHNOLOGY
25 Oct 2019
Share Share
Aurobindo chalks up new FDA manufacturing concerns

Aurobindo chalks up new FDA manufacturing concerns
E.Palmer FIERCE PHARMA
09 Oct 2019
Share Share
FDA cites solvent recovery firm as a player in the valsartan mess

FDA cites solvent recovery firm as a player in the valsartan mess
Eric Palmer FIERCE PHARMA
16 Aug 2019
Share Share